semaglutide shots for weight loss near me Injections Semaglutide Weight Loss Treatment: GLP-1

However, severe vomiting lasting hours or signs of dehydration require immediate medical attention

Shift 2: Off-label GLP-1 use for obesity became explicitly excluded

Nausea: 246% increased risk , Vomiting 325% increased risk , Diarrhea 137% increased risk , and Drug discontinuation due to these adverse events :161% increased risk

If you have been researching these two peptides, you probably want a clear, honest comparison before you make a decision

Use of semaglutide for this indication is supported by a 68-week, double-blind, placebo-controlled clinical trial in pediatric patients and from studies in adult patients with obesity